BioCryst Pharmaceuticals Inc

BCRX

Add to Watchlist

9.995USD

-0.595-5.62%

Market hours （ET）Quotes delayed by 15 min

2.55BMarket Cap

LossP/E TTM

BioCryst Pharmaceuticals Inc

9.995

-0.595-5.62%

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Follow the latest BioCryst Pharmaceuticals Inc stock news, earnings, analyst ratings and key developments.

Recent

BioCryst Q2 2026 earnings: Licensing revenue lifts operating profit

TradingKey Wed, Aug 5